These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37735514)

  • 1. BRAF
    Rzasa P; Whelan S; Farahmand P; Cai H; Guterman I; Palacios-Gallego R; Undru SS; Sandford L; Green C; Andreadi C; Mintseva M; Parrott E; Jin H; Hey F; Giblett S; Sylvius NB; Allcock NS; Straatman-Iwanowska A; Feuda R; Tufarelli C; Brown K; Pritchard C; Rufini A
    Commun Biol; 2023 Sep; 6(1):962. PubMed ID: 37735514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRAF
    Sakamoto N; Feng Y; Stolfi C; Kurosu Y; Green M; Lin J; Green ME; Sentani K; Yasui W; McMahon M; Hardiman KM; Spence JR; Horita N; Greenson JK; Kuick R; Cho KR; Fearon ER
    Elife; 2017 Jan; 6():. PubMed ID: 28072391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAF
    Trivieri N; Pracella R; Cariglia MG; Panebianco C; Parrella P; Visioli A; Giani F; Soriano AA; Barile C; Canistro G; Latiano TP; Dimitri L; Bazzocchi F; Cassano D; Vescovi AL; Pazienza V; Binda E
    J Exp Clin Cancer Res; 2020 Dec; 39(1):285. PubMed ID: 33317591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved molecular classification of serrated lesions of the colon by immunohistochemical detection of BRAF V600E.
    Mesteri I; Bayer G; Meyer J; Capper D; Schoppmann SF; von Deimling A; Birner P
    Mod Pathol; 2014 Jan; 27(1):135-44. PubMed ID: 23887306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VE1 immunohistochemistry accurately detects BRAF V600E mutations in colorectal carcinoma and can be utilized in the detection of poorly differentiated colorectal serrated adenocarcinoma.
    Sajanti S; Sirniö P; Väyrynen JP; Tuomisto A; Klintrup K; Mäkelä J; Ristimäki A; Mäkinen MJ
    Virchows Arch; 2014 Jun; 464(6):637-43. PubMed ID: 24722974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis.
    Minoo P; Moyer MP; Jass JR
    J Pathol; 2007 Jun; 212(2):124-33. PubMed ID: 17427169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRAF
    Reischmann N; Andrieux G; Griffin R; Reinheckel T; Boerries M; Brummer T
    Oncogene; 2020 Sep; 39(38):6053-6070. PubMed ID: 32792685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMAD4 is critical in suppression of BRAF-V600E serrated tumorigenesis.
    Tong K; Kothari OA; Haro KS; Panda A; Bandari MM; Carrick JN; Hur JJ; Zhang L; Chan CS; Xing J; Gatza ML; Ganesan S; Verzi MP
    Oncogene; 2021 Oct; 40(41):6034-6048. PubMed ID: 34453124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic BRAF mutation induces DNA methylation changes in a murine model for human serrated colorectal neoplasia.
    Bond CE; Liu C; Kawamata F; McKeone DM; Fernando W; Jamieson S; Pearson SA; Kane A; Woods SL; Lannagan TRM; Somashekar R; Lee Y; Dumenil T; Hartel G; Spring KJ; Borowsky J; Fennell L; Bettington M; Lee J; Worthley DL; Leggett BA; Whitehall VLJ
    Epigenetics; 2018; 13(1):40-48. PubMed ID: 29235923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
    Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I
    Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical Examination is Highly Sensitive and Specific for Detection of the V600E BRAF Mutation in Colorectal Serrated Lesions.
    Yamada N; Eizuka M; Sugimoto R; Tanaka Y; Yanagawa N; Yamano H; Suzuki H; Matsumoto T; Sugai T
    Appl Immunohistochem Mol Morphol; 2021 Jul; 29(6):446-453. PubMed ID: 33306619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in BRAF-Mutated Colorectal Cancers.
    Tang Z; Yuan X; Du R; Cheung SH; Zhang G; Wei J; Zhao Y; Feng Y; Peng H; Zhang Y; Du Y; Hu X; Gong W; Liu Y; Gao Y; Liu Y; Hao R; Li S; Wang S; Ji J; Zhang L; Li S; Sutton D; Wei M; Zhou C; Wang L; Luo L
    Mol Cancer Ther; 2015 Oct; 14(10):2187-97. PubMed ID: 26208524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF
    Dizdar L; Werner TA; Drusenheimer JC; Möhlendick B; Raba K; Boeck I; Anlauf M; Schott M; Göring W; Esposito I; Stoecklein NH; Knoefel WT; Krieg A
    Int J Cancer; 2019 Mar; 144(6):1379-1390. PubMed ID: 30144031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial-Driven Inflammation and Mutant
    DeStefano Shields CE; White JR; Chung L; Wenzel A; Hicks JL; Tam AJ; Chan JL; Dejea CM; Fan H; Michel J; Maiuri AR; Sriramkumar S; Podicheti R; Rusch DB; Wang H; De Marzo AM; Besharati S; Anders RA; Baylin SB; O'Hagan HM; Housseau F; Sears CL
    Cancer Discov; 2021 Jul; 11(7):1792-1807. PubMed ID: 33632774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reappraisal of the genetic heterogeneity of sessile serrated adenoma/polyp.
    Cho H; Hashimoto T; Yoshida H; Taniguchi H; Ogawa R; Mori T; Hiraoka N; Saito Y; Sekine S
    Histopathology; 2018 Oct; 73(4):672-680. PubMed ID: 29920740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic mutation in RAS-RAF axis leads to increased expression of GREB1, resulting in tumor proliferation in colorectal cancer.
    Kochi M; Hinoi T; Niitsu H; Miguchi M; Saito Y; Sada H; Sentani K; Sakamoto N; Oue N; Tashiro H; Sotomaru Y; Yasui W; Ohdan H
    Cancer Sci; 2020 Oct; 111(10):3540-3549. PubMed ID: 32629543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific activation of glycolytic enzyme enolase 2 in BRAF V600E-mutated colorectal cancer.
    Yukimoto R; Nishida N; Hata T; Fujino S; Ogino T; Miyoshi N; Takahashi H; Uemura M; Satoh T; Hirofumi Y; Mizushima T; Doki Y; Eguchi H
    Cancer Sci; 2021 Jul; 112(7):2884-2894. PubMed ID: 33934428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAF V600E immunohistochemistry demonstrates that some sessile serrated lesions with adenomatous dysplasia may represent collision lesions.
    Bettington M; Liu C; Gill A; Walker N; Leggett B; Whitehall V; Rosty C
    Histopathology; 2019 Jul; 75(1):81-87. PubMed ID: 30825335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic BRAF-V600E mutations in familial colorectal cancer.
    Vandrovcova J; Lagerstedt-Robinsson K; Påhlman L; Lindblom A
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2270-3. PubMed ID: 17119056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological factors associated with BRAF-V600E mutation in colorectal serrated adenomas.
    Travaglino A; D'Armiento FP; Cassese G; Campanino MR; Borrelli G; Pignatiello S; Luglio G; Maione F; De Palma GD; D'Armiento M
    Histopathology; 2019 Aug; 75(2):160-173. PubMed ID: 30815911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.